For example, although studies suggesting that IL-33 may serve as a biomarker for early chronic kidney disease exist (145), some studies have suggested that the challenging measurement of serum IL-33 concentrations may lead to false-positive results, prompting further accurate studies of IL-33 expression levels in serum samples (146). This evidence concerns the gene IL33 and chronic kidney disease.